OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

I believe ONCS will present here as well: World Cutaneous Congress. Hauschild is ours and Bhatia is the investigator for MCC. What do you think?

General Session III: Emerging Therapies, Combos, and Targeted Agents
Changing arena of adjuvant therapy in malignant melanoma - Reinhard Dummer, MD, PhD
Ongoing clinical studies in BCC - Aleksandar Sekulic, MD, PhD
New systemic therapies in CTCL: Beyond the old paradigms - Steve Horowitz
Emerging treatment options in MCC: Chemotherapy and alternative approaches for metastatic disease - Shailender Bhatia, MD

General Session II: Current Treatment Algorithms in Cutaneous Malignancies
Current approaches to therapy in malignant melanoma: the US perspective - Antoni Ribas, MD
Current approaches to therapy in malignant melanoma: the EU perspective - Axel Hauschild, MD
Current treatment options for advanced BCC - Karl Lewis, MD
Current treatment options in CTCL - Pierluigi Porcu, MD
Update on NCCN guidelines for the management of MCC - Christopher K. Bichakjian, MD

http://www.cutaneousmalignancies.com/conference/agenda